Cargando…
Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA
To date, no medical therapy can slow the progression of aortic stenosis. Fibrocalcific stenosis is the most frequent form in the general population and affects about 6% of the elderly population. Over the years, diagnosis has evolved thanks to echocardiography and computed tomography assessments. Th...
Autores principales: | Di Costanzo, Assunta, Indolfi, Ciro, Franzone, Anna, Esposito, Giovanni, Spaccarotella, Carmen Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573862/ https://www.ncbi.nlm.nih.gov/pubmed/37834387 http://dx.doi.org/10.3390/ijms241914939 |
Ejemplares similares
-
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022) -
SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases
por: Di Costanzo, Assunta, et al.
Publicado: (2023) -
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023) -
Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis—Management of Aortic Stenosis with TAVIApp
por: Indolfi, Ciro, et al.
Publicado: (2017) -
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis
por: Polimeni, Alberto, et al.
Publicado: (2020)